MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
MacroGenics (MGNX) Reports Q1 Loss, Tops Revenue Estimates
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
Will MacroGenics (MGNX) Report Negative Q1 Earnings? What You Should Know
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study
MacroGenics (NASDAQ:MGNX) & Medtronic (NYSE:MDT) Critical Review
MacroGenics, Inc. (MGNX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
MacroGenics to Participate in Upcoming Investor Conferences
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Head to Head Review: MacroGenics (NASDAQ:MGNX) & Sharps Technology (NASDAQ:STSS)
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
MacroGenics: Working On That Road To Recovery
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
4 Medical Product Stocks to Watch From a Challenging Industry
MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates
MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results
MacroGenics Announces Date of First Quarter 2025 Financial Results
MacroGenics to Participate in Upcoming Investor Conference
4 Medical Product Stocks to Buy From a Challenging Industry
MacroGenics (MGNX) Loses -48.74% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
MacroGenics (MGNX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates
MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
MacroGenics: Stacking Up A Lot Of Headwinds
MacroGenics to Participate in Upcoming Investor Conferences
MGNX ALERT: Bragar Eagel & Squire, P.C. is Investigating Macrogenics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
MacroGenics to Participate in Upcoming Investor Conference
MacroGenics to Participate in Upcoming Investor Conferences
Here's What Key Metrics Tell Us About MacroGenics (MGNX) Q3 Earnings
MacroGenics (MGNX) Beats Q3 Earnings and Revenue Estimates
MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
MacroGenics Announces Leadership Transition
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders